- Home
- HUIZ vs HCWB Comparison
HUIZ vs HCWB Comparison
Compare HUIZ & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HUIZ
- HCWB
- Stock Information
- Founded
- HUIZ 2006
- HCWB 2018
- Country
- HUIZ China
- HCWB United States
- Employees
- HUIZ N/A
- HCWB N/A
- Industry
- HUIZ Specialty Insurers
- HCWB Biotechnology: Pharmaceutical Preparations
- Sector
- HUIZ Finance
- HCWB Health Care
- Exchange
- HUIZ Nasdaq
- HCWB Nasdaq
- Market Cap
- HUIZ 32.0M
- HCWB 26.6M
- IPO Year
- HUIZ 2020
- HCWB 2021
- Fundamental
- Price
- HUIZ $3.05
- HCWB $0.34
- Analyst Decision
- HUIZ
- HCWB
- Analyst Count
- HUIZ 0
- HCWB 0
- Target Price
- HUIZ N/A
- HCWB N/A
- AVG Volume (30 Days)
- HUIZ 39.7K
- HCWB 226.8K
- Earning Date
- HUIZ 03-19-2025
- HCWB 11-14-2024
- Dividend Yield
- HUIZ N/A
- HCWB N/A
- EPS Growth
- HUIZ N/A
- HCWB N/A
- EPS
- HUIZ 0.29
- HCWB N/A
- Revenue
- HUIZ $170,927,079.00
- HCWB $3,495,990.00
- Revenue This Year
- HUIZ N/A
- HCWB $229.19
- Revenue Next Year
- HUIZ $10.46
- HCWB N/A
- P/E Ratio
- HUIZ $10.82
- HCWB N/A
- Revenue Growth
- HUIZ N/A
- HCWB 22.27
- 52 Week Low
- HUIZ $2.15
- HCWB $0.28
- 52 Week High
- HUIZ $10.58
- HCWB $2.52
- Technical
- Relative Strength Index (RSI)
- HUIZ 47.47
- HCWB 39.56
- Support Level
- HUIZ $2.86
- HCWB $0.33
- Resistance Level
- HUIZ $3.19
- HCWB $0.39
- Average True Range (ATR)
- HUIZ 0.33
- HCWB 0.05
- MACD
- HUIZ -0.01
- HCWB -0.00
- Stochastic Oscillator
- HUIZ 35.29
- HCWB 6.54
About HUIZ Huize Holding Limited
Huize Holding Ltd is an independent online insurance product and service platform in China. The company distributes on its platform insurance products underwritten by the insurance companies who cooperate with the company, who the company refers to as its insurer partners, and helps them reach a large number of insurance clients. The company's platform offers digitalized insurance purchase experience and services through various internet and mobile internet channels. The company generates revenues from the insurance brokerage fees paid by its insurer partners.
About HCWB HCW Biologics Inc.
HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.